- CEO
- Hong Loon Gan
- Full Time Employees
- 10
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 83 Science Park Dr Singapore CE Singapore 118258
- IPO Date
- Nov 13, 2025
- Business
- Phaos Technology Holdings (Cayman) Limited is a Cayman Islands-incorporated investment holding company that, through its wholly-owned subsidiary Phaos Technology Pte. Ltd., assembles and commercializes advanced microscopy-related solutions, technologies and products leveraging patented microsphere-assisted super-resolution technology to achieve imaging below the 200nm optical limit; its core product portfolio includes Optonano for live and still high-quality imaging of larger sample areas, PT-Industrial for material study, failure analysis, quality control, inspection and manufacturing applications, PT-Metrology for single-key dimensional measurements, PT-Biology for specialized biomedical imaging, PT-Stereo for clear magnified stereoscopic views of solid or thick samples, and PT-Zoom for three-dimensional real-time magnification, complemented by proprietary in-house artificial intelligence-powered software for pattern recognition, research, quality assurance, diagnostics and seamless hardware integration. The company serves diverse customers in manufacturing sectors such as printed circuit boards, electronics, precision engineering and injection molding; biomedical service providers; research and development institutions; semiconductors; and healthcare, primarily through an extensive distributor network in Singapore, Vietnam, Southeast Asia and South Asia. Founded in 2017 and headquartered at 83 Science Park Drive, The Curie, Singapore Science Park 1, Singapore, Phaos Technology Holdings operates in the electronic equipment and instruments industry with 24 employees and focuses on strengthening its Singapore market position while expanding regionally. Recent developments include its initial public offering on the NYSE American under ticker POAS in November 2025, raising approximately $14.4 million initially and an additional $1.62 million from the over-allotment option of 405,500 Class A ordinary shares closed on November 24, 2025, underwritten by Network 1 Financial Securities, with no other major acquisitions, partnerships or product launches reported in the past year. Its subsidiaries encompass Phaos Technology Pte. Ltd. and Phaos Technology Holdings (BVI) Limited, supporting microscopy solutions for precision measurement, magnification and quality control across industrial, biomedical and R&D applications.